Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

Presentation Miami Valves 2024

New Cerebral Protection Devices for TAVR

Presenter: Fábio S. Brito Jr.

February 03, 2024

Presentation TCT 2020

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Presenter: David Cohen

October 16, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

Presentation Live Valves 2019

TAVI: Cerebral Protection for Everyone

Presenter: Susheel Kodali

December 10, 2019

Presentation SIF 2019

Debate Cerebral Embolic Protection: The Data are Compelling and the Costs Manageable

Presenter: Saif Anwaruddin

March 30, 2019

Presentation SIF 2019

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

March 30, 2019

Presentation SIF 2019

Cerebral Embolic Protection In the Setting of TAVR

Presenter: David G. Rizik

March 28, 2019

Presentation CIT 2019

Cerebral Protection in TAVR

Presenter: Alexandra Lansky

March 28, 2019

Presentation JIM 2019

Optimizing your TAVI program with Cerebral embolic protection: a case based approach

Presenter: Francesco Bedogni

February 14, 2019

Presentation SCAI 2018

Cerebral Embolic Protection: Protect Everyone

Presenter: Samir Kapadia

April 28, 2018

Presentation SCAI 2018

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

April 28, 2018

Presentation TVT 2017

The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection

Presenter: Axel Linke, Jeffrey J. Popma, Samir R. Kapadia

June 15, 2017

Presentation TVT 2017

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

Presenter: Axel Linke, Jeffrey J. Popma, Susheel Kodali

June 15, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Presentation TVT 2017

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

Presenter: Jochen Wöhrle

June 15, 2017

Presentation TVT 2017

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem

June 15, 2017

Presentation ACC 2017

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Michael Mack

March 20, 2017

Presentation JIM 2017

Complete Cerebral Embolic Protection Utilizing TriGuard™

Presenter: Azeem Latib

February 10, 2017

Presentation

CLEAN-TAVI: Effect of a Cerebral Protection Device on Brain Lesions Following TAVR in Patients With Severe Aortic Stenosis

Presenter: S. Haussing

August 11, 2016

Advertisement

New Cerebral Protection Devices for TAVR

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

TAVI: Cerebral Protection for Everyone

Debate Cerebral Embolic Protection: The Data are Compelling and the Costs Manageable

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Cerebral Embolic Protection In the Setting of TAVR

Cerebral Protection in TAVR

Optimizing your TAVI program with Cerebral embolic protection: a case based approach

Cerebral Embolic Protection: Protect Everyone

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection

The SENTINEL Trial: Safety and Effectiveness of Cerebral Embolic Protection During TAVR

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

A Description of the U.S. REFLECT Randomized Clinical Trial

A Propensity Score Analysis of Matched TAVR Patients With and Without Cerebral Protection

The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Complete Cerebral Embolic Protection Utilizing TriGuard™

CLEAN-TAVI: Effect of a Cerebral Protection Device on Brain Lesions Following TAVR in Patients With Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content